[HTML][HTML] FKBP10/FKBP65 expression in high-grade ovarian serous carcinoma and its association with patient outcome

MCJ Quinn, PM Wojnarowicz… - International …, 2013 - spandidos-publications.com
The frequent loss of chromosome 17 in epithelial ovarian carcinomas (EOC), particularly
high-grade serous carcinomas (HGSC), has been attributed to the disruption of TP53 (at 17p13. …

[HTML][HTML] The Genomic Landscape of TP53 and p53 Annotated High Grade Ovarian Serous Carcinomas from a Defined Founder Population Associated with Patient …

PM Wojnarowicz, KK Oros, MCJ Quinn, SL Arcand… - 2012 - journals.plos.org
High-grade ovarian serous carcinomas (HGSC) are characterized by TP53 mutations and
non-random patterns of chromosomal anomalies, where the nature of the TP53 mutation may …

[HTML][HTML] VGLL3 expression is associated with a tumor suppressor phenotype in epithelial ovarian cancer

…, PM Wojnarowicz, SL Arcand, M de Ladurantaye… - Molecular …, 2013 - Elsevier
Previous studies have implicated vestigial like 3 (VGLL3), a chromosome 3p12.3 gene that
encodes a putative transcription co-factor, as a candidate tumor suppressor gene (TSG) in …

[PDF][PDF] A small-molecule pan-Id antagonist inhibits pathologic ocular neovascularization

PM Wojnarowicz, RL e Silva, M Ohnaka, SB Lee… - Cell reports, 2019 - cell.com
Id helix-loop-helix (HLH) proteins (Id1–4) bind E protein bHLH transcription factors, preventing
them from forming active transcription complexes that drive changes in cell states. Id …

[HTML][HTML] Anti-tumor effects of an ID antagonist with no observed acquired resistance

PM Wojnarowicz, MG Escolano, YH Huang… - NPJ Breast …, 2021 - nature.com
ID proteins are helix-loop-helix (HLH) transcriptional regulators frequently overexpressed in
cancer. ID proteins inhibit basic-HLH transcription factors often blocking differentiation and …

Chromosome 17q25 genes, RHBDF2 and CYGB, in ovarian cancer

PM Wojnarowicz, DM Provencher… - International …, 2012 - spandidos-publications.com
It has been proposed that the frequent loss of heterozygosity (LOH) of an entire chromosome
17 contig in epithelial ovarian cancers (EOC) is the consequence of the inactivation of …

HPMA–copolymer nanocarrier targets tumor-associated macrophages in primary and metastatic breast cancer

…, AB Christ, X Wei, J Wu, PM Wojnarowicz… - Molecular cancer …, 2017 - AACR
Polymeric nanocarriers such as N-(2-hydroxypropyl) methacrylamide (HPMA) copolymers
deliver drugs to solid tumors and avoid the systemic toxicity of conventional chemotherapy. …

[HTML][HTML] The chemiluminescence based Ziplex® automated workstation focus array reproduces ovarian cancer Affymetrix GeneChip® expression profiles

…, SL Arcand, AH Birch, PM Wojnarowicz… - Journal of Translational …, 2009 - Springer
Background As gene expression signatures may serve as biomarkers, there is a need to
develop technologies based on mRNA expression patterns that are adaptable for translational …

Anti-tumor effects of an Id antagonist with no acquired resistance

PM Wojnarowicz, MG Escolano, YH Huang, B Desai… - bioRxiv, 2020 - biorxiv.org
Id proteins are helix-loop-helix (HLH) transcriptional regulators frequently overexpressed in
cancer. Id proteins inhibit basic HLH transcription factors through protein-protein interactions…

Abstract A30: Activation of GCN2 by HC-7366 results in significant anti-tumor efficacy as monotherapy and in combination with Venetoclax in AML models

F Tameire, PM Wojnarowicz, S Fujisawa, S Huang… - Blood Cancer …, 2023 - AACR
The integrated stress response (ISR) is an adaptive signaling pathway that cells utilize to
respond to a wide range of extrinsic and intrinsic stresses, many of which are important for …